Generalized Anxiety Disorder
Severe, ongoing anxiety that interferes with daily activities.
Generalized anxiety disorder can occur at any age.
The condition has symptoms similar to panic disorder, obsessive-compulsive disorder, and other types of anxiety. These symptoms include constant worry, restlessness, and trouble with concentration.
Treatment may include counseling and medications, such as antidepressants.
Cluster Number:
Wiki Number:
Diagnosis: W090
US Patients: Generalized Anxiety Disorder
World Patients: 3-5%
Sex Ratio:
Age Onset: M;W2
Brain Area: Age 31
Symptoms: more amygdala and medial pfc activities; hippocampus, insula & orbitofrontal cortex
Progression: excessive, uncotnrollable and often irrational worry about ev ents or activities. frequent autonomic arousal
Causes: 60% develop depression
Medications: may be hereditary (40%)or genetic + environment-actual experiences
Therapies: norepinephrine inhibitors, antianxiety drugs, (many, many drug options-but many with possibly fatal side effects)
CBT-less catastrophizing, and other CBT orientations, relaxation, mindfulness, physical exercise
Youtube Video: What is Generalized Anxiety Disorder?
Amazon or Library Book: Overcoming Generalized Anxiety Disorder
Support Group: nami.org; 800-950-6264 (National Alliance on Mental Illness)
Contact you local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.06
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- A pilot study of low-intensity focused ultrasound for treatment-resistant generalized anxiety disorderby Kennedy D Mahdavi on November 4, 2024
CONCLUSION: This study provides preliminary evidence supporting the safety and efficacy of tfUS as a clinical intervention. These results warrant further investigation of tfUS as a therapeutic intervention for anxiety and other psychiatric and neurological disorders.
- Income in Relation to Psychosocial Factors Among Stroke Survivors using Smartwatches for Atrial Fibrillation Monitoringby Syed Naeem on November 4, 2024
CONCLUSION: Our findings demonstrate that low SES is associated with worse self-reporting of physical health status, and this may influence psychosocial outcomes in smartwatch users.
- Validation study of the Korean version of the COVID-19 Anxiety Scale (CAS-7) and psychometric comparison of different rating scalesby C Hyung Keun Park on November 4, 2024
We aimed to explore the validity and reliability of the Korean version of the COVID-19 Anxiety Scale (CAS-7) among the general population and compare the psychometric properties of the CAS-7 with major rating scales for viral anxiety according to the generalized anxiety disorder-7 (GAD-7) during the coronavirus disease 2019 (COVID-19) pandemic. This anonymous online survey was conducted among the general population in South Korea during November 9-15, 2021, and 400 people participated. The...
- Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experienceby Ciprian Jitaru on November 4, 2024
CONCLUSIONS: Our results suggest that siltuximab-based therapy is effective in treating iMCD in real-world settings in Greece and Romania. To our knowledge, this study represents the largest real-world analysis of siltuximab in European patients with iMCD so far.